Cardiac disease in pregnancy and drug therapy: Difference between revisions
Jump to navigation
Jump to search
Line 21: | Line 21: | ||
==Acceptable Drugs== | ==Acceptable Drugs== | ||
* [[ASA]] - low dose | * [[ASA]] - low dose | ||
* Nitrates – use low dose to prevent fetal distress | * [[Nitrates]] – use low dose to prevent fetal distress | ||
* [[Hydralazine]] | |||
* Beta-1 selective [[Beta-blockers]] like lopressor, metoprolol. | * Beta-1 selective [[Beta-blockers]] like lopressor, metoprolol. | ||
* [[Magnesium]] | * [[Magnesium]] | ||
* Morphine sulfate | * [[Morphine sulfate]] | ||
* [[Diuretics]] can reduce placental perfusion and should be used sparingly |
Revision as of 01:00, 11 October 2012
Cardiac disease in pregnancy Microchapters |
Diagnosis |
---|
Catheterization: |
Treatment |
Special Scenarios:
|
Cardiac disease in pregnancy and drug therapy On the Web |
American Roentgen Ray Society Images of Cardiac disease in pregnancy and drug therapy |
Directions to Hospitals Treating Cardiac disease in pregnancy |
Risk calculators and risk factors for Cardiac disease in pregnancy and drug therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
ACE inhibtors, Angiotensin receptor blockers (ARBss), and warfarin should be avoided in pregnancy.
Contraindicated Drugs
Drugs to be Avoided
- Atenolol
- Carvedilol
- Thrombolytics efficacy and safety is mostly untested
- Greatest experience in massive pulmonary embolism
- Streptokinase does not cross placental membrane in animals, but Ab found in neonatal spinal cord fluid
- Urokinase not teratogenic in mice/rats
- Risk for maternal hemorrhage (1 case of placental abruption reported); increased risk when given at time of delivery
- Delivery best delayed at least 2-3 weeks
Acceptable Drugs
- ASA - low dose
- Nitrates – use low dose to prevent fetal distress
- Hydralazine
- Beta-1 selective Beta-blockers like lopressor, metoprolol.
- Magnesium
- Morphine sulfate
- Diuretics can reduce placental perfusion and should be used sparingly